Trials / Unknown
UnknownNCT01889017
Generic Immunosuppressive Drugs After Lung Transplantation
Generic Immunosuppressive Drugs After Lung Transplantation - a Crosssectional Observational Study by Patient Questionnaire
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Hannover Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Extent of use of generics immunosuppressive drugs in clinical practice after lung transplantation
Detailed description
Solid organ transplant recipients are treated with immunosuppressive drugs to prevent rejection of their grafts. The most frequently important maintenance immunosuppressive drugs in Europe are calcineurin inhibitors. For a number of these compounds drug patents have expired in recent years and generic formulations have entered the market. There is considerable debate regarding the efficacy and safety of generic drug substitution in solid organ recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | patient questionnaire (tablet pc based) |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-03-01
- Completion
- 2014-09-01
- First posted
- 2013-06-28
- Last updated
- 2013-07-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01889017. Inclusion in this directory is not an endorsement.